![8JE 8JE](https://data.pdbj.org/pdbjplus/data/cc/svg/8JE.svg) | 8JE | Name: | 5-(4-fluorophenyl)-~{N}-[[3-[(~{S})-(1-methylindazol-5-yl)-oxidanyl-methyl]phenyl]methyl]-2,3-bis(oxidanyl)benzamide | Formula: | C29 H24 F N3 O4 | SMILES: | Cn1ncc2cc(ccc12)[CH](O)c3cccc(CNC(=O)c4cc(cc(O)c4O)c5ccc(F)cc5)c3 | InChi: | InChI=1S/C29H24FN3O4/c1-33-25-10-7-20(12-22(25)16-32-33)27(35)19-4-2-3-17(11-19)15-31-29(37)24-13-21(14-26(34)28(24)36)18-5-8-23(30)9-6-18/h2-14,16,27,34-36H,15H2,1H3,(H,31,37)/t27-/m0/s1 | Definition date: | 2016-12-17 | Last modified: | 2017-11-17 | Release date: | 2017-11-22 | Identifier: | 5-(4-fluorophenyl)-~{N}-[[3-[(~{S})-(1-methylindazol-5-yl)-oxidanyl-methyl]phenyl]methyl]-2,3-bis(oxidanyl)benzamide |
|
![A1C A1C](https://data.pdbj.org/pdbjplus/data/cc/svg/A1C.svg) | A1C | Name: | 1-(3-chloro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide | Formula: | C20 H23 Cl N2 O3 S | SMILES: | c1(cc(Cl)c(C)cc1)CS(Nc3cc2CCC(N(CCC)c2cc3)=O)(=O)=O | InChi: | InChI=1S/C20H23ClN2O3S/c1-3-10-23-19-8-7-17(12-16(19)6-9-20(23)24)22-27(25,26)13-15-5-4-14(2)18(21)11-15/h4-5,7-8,11-12,22H,3,6,9-10,13H2,1-2H3 | Definition date: | 2017-05-16 | Last modified: | 2017-11-10 | Release date: | 2017-11-15 | Identifier: | 1-(3-chloro-4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide |
|
![DK7 DK7](https://data.pdbj.org/pdbjplus/data/cc/svg/DK7.svg) | DK7 | Name: | N-[(1S,2S)-1-[(3R,6R)-6-(cyclohexylmethoxy)morpholin-3-yl]-3-(3,5-difluorophenyl)-1-hydroxypropan-2-yl]acetamide | Formula: | C22 H32 F2 N2 O4 | SMILES: | c3(cc(CC(C(O)C2NCC(OCC1CCCCC1)OC2)NC(C)=O)cc(c3)F)F | InChi: | InChI=1S/C22H32F2N2O4/c1-14(27)26-19(9-16-7-17(23)10-18(24)8-16)22(28)20-13-30-21(11-25-20)29-12-15-5-3-2-4-6-15/h7-8,10,15,19-22,25,28H,2-6,9,11-13H2,1H3,(H,26,27)/t19-,20+,21+,22-/m0/s1 | Definition date: | 2017-10-30 | Last modified: | 2017-11-10 | Release date: | 2017-11-15 | Identifier: | N-[(1S,2S)-1-[(3R,6R)-6-(cyclohexylmethoxy)morpholin-3-yl]-3-(3,5-difluorophenyl)-1-hydroxypropan-2-yl]acetamide |
|
![DKJ DKJ](https://data.pdbj.org/pdbjplus/data/cc/svg/DKJ.svg) | DKJ | Name: | N-{(1S,2S)-3-(3,5-difluorophenyl)-1-[(3R,5S,6R)-6-(2,2-dimethylpropoxy)-5-methylmorpholin-3-yl]-1-hydroxypropan-2-yl}acetamide | Formula: | C21 H32 F2 N2 O4 | SMILES: | O=C(C)NC(Cc1cc(cc(c1)F)F)C(C2NC(C)C(OC2)OCC(C)(C)C)O | InChi: | InChI=1S/C21H32F2N2O4/c1-12-20(29-11-21(3,4)5)28-10-18(24-12)19(27)17(25-13(2)26)8-14-6-15(22)9-16(23)7-14/h6-7,9,12,17-20,24,27H,8,10-11H2,1-5H3,(H,25,26)/t12-,17-,18+,19-,20-/m0/s1 | Definition date: | 2017-10-30 | Last modified: | 2017-11-10 | Release date: | 2017-11-15 | Identifier: | N-{(1S,2S)-3-(3,5-difluorophenyl)-1-[(3R,5S,6R)-6-(2,2-dimethylpropoxy)-5-methylmorpholin-3-yl]-1-hydroxypropan-2-yl}acetamide |
|
![BUY BUY](https://data.pdbj.org/pdbjplus/data/cc/svg/BUY.svg) | BUY | Name: | 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid | Formula: | C27 H21 Cl N6 O4 | SMILES: | OC(=O)c1ccc(NC(=O)[CH]2N(CCc3ccccc23)C(=O)C=Cc4cc(Cl)ccc4n5cnnn5)cc1 | InChi: | InChI=1S/C27H21ClN6O4/c28-20-8-11-23(34-16-29-31-32-34)19(15-20)7-12-24(35)33-14-13-17-3-1-2-4-22(17)25(33)26(36)30-21-9-5-18(6-10-21)27(37)38/h1-12,15-16,25H,13-14H2,(H,30,36)(H,37,38)/b12-7+/t25-/m0/s1 | Definition date: | 2017-08-25 | Last modified: | 2017-11-03 | Release date: | 2017-11-08 | Identifier: | 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid |
|
![BVJ BVJ](https://data.pdbj.org/pdbjplus/data/cc/svg/BVJ.svg) | BVJ | Name: | methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]phenyl]carbamate | Formula: | C28 H23 Cl F N7 O4 | SMILES: | COC(=O)Nc1ccc(NC(=O)[CH]2N(CCc3ccccc23)C(=O)C=Cc4c(F)c(Cl)ccc4n5cnnn5)cc1 | InChi: | InChI=1S/C28H23ClFN7O4/c1-41-28(40)33-19-8-6-18(7-9-19)32-27(39)26-20-5-3-2-4-17(20)14-15-36(26)24(38)13-10-21-23(37-16-31-34-35-37)12-11-22(29)25(21)30/h2-13,16,26H,14-15H2,1H3,(H,32,39)(H,33,40)/b13-10+/t26-/m0/s1 | Definition date: | 2017-08-25 | Last modified: | 2017-11-03 | Release date: | 2017-11-08 | Identifier: | methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]phenyl]carbamate |
|
![BVM BVM](https://data.pdbj.org/pdbjplus/data/cc/svg/BVM.svg) | BVM | Name: | 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~{S})-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid | Formula: | C36 H34 Cl N7 O7 | SMILES: | CCOC(=O)[CH]1CCCN(C1)C(=O)c2cccc3[CH](N(CCc23)C(=O)C=Cc4cc(Cl)ccc4n5cnnn5)C(=O)Nc6ccc(cc6)C(O)=O | InChi: | InChI=1S/C36H34ClN7O7/c1-2-51-36(50)24-5-4-17-42(20-24)34(47)29-7-3-6-28-27(29)16-18-43(32(28)33(46)39-26-12-8-22(9-13-26)35(48)49)31(45)15-10-23-19-25(37)11-14-30(23)44-21-38-40-41-44/h3,6-15,19,21,24,32H,2,4-5,16-18,20H2,1H3,(H,39,46)(H,48,49)/b15-10+/t24-,32-/m0/s1 | Definition date: | 2017-08-25 | Last modified: | 2017-11-03 | Release date: | 2017-11-08 | Identifier: | 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~{S})-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid |
|
![A6E A6E](https://data.pdbj.org/pdbjplus/data/cc/svg/A6E.svg) | A6E | Name: | 3-(4-fluoranylphenoxy)-1-thiomorpholin-4-yl-propan-1-one | Formula: | C13 H16 F N O2 S | SMILES: | Fc1ccc(OCCC(=O)N2CCSCC2)cc1 | InChi: | InChI=1S/C13H16FNO2S/c14-11-1-3-12(4-2-11)17-8-5-13(16)15-6-9-18-10-7-15/h1-4H,5-10H2 | Definition date: | 2017-08-16 | Last modified: | 2017-10-27 | Release date: | 2017-11-01 | Identifier: | 3-(4-fluoranylphenoxy)-1-thiomorpholin-4-yl-propan-1-one |
|
![7NQ 7NQ](https://data.pdbj.org/pdbjplus/data/cc/svg/7NQ.svg) | 7NQ | Name: | ~{N}-(4-ethoxyquinazolin-2-yl)propanamide | Formula: | C13 H15 N3 O2 | SMILES: | CCOc1nc(NC(=O)CC)nc2ccccc12 | InChi: | InChI=1S/C13H15N3O2/c1-3-11(17)15-13-14-10-8-6-5-7-9(10)12(16-13)18-4-2/h5-8H,3-4H2,1-2H3,(H,14,15,16,17) | Definition date: | 2016-11-28 | Last modified: | 2017-10-27 | Release date: | 2017-11-01 | Identifier: | ~{N}-(4-ethoxyquinazolin-2-yl)propanamide |
|
![7NT 7NT](https://data.pdbj.org/pdbjplus/data/cc/svg/7NT.svg) | 7NT | Name: | ~{N}-(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)propanamide | Formula: | C13 H16 N4 O2 S | SMILES: | CCC(=O)Nc1nc2sccc2c(n1)N3CCOCC3 | InChi: | InChI=1S/C13H16N4O2S/c1-2-10(18)14-13-15-11(17-4-6-19-7-5-17)9-3-8-20-12(9)16-13/h3,8H,2,4-7H2,1H3,(H,14,15,16,18) | Definition date: | 2016-11-28 | Last modified: | 2017-10-27 | Release date: | 2017-11-01 | Identifier: | ~{N}-(4-morpholin-4-ylthieno[2,3-d]pyrimidin-2-yl)propanamide |
|
![8AS 8AS](https://data.pdbj.org/pdbjplus/data/cc/svg/8AS.svg) | 8AS | Name: | 3-(morpholin-4-yl)propanoic acid | Formula: | C7 H13 N O3 | SMILES: | O=C(CCN1CCOCC1)O | InChi: | InChI=1S/C7H13NO3/c9-7(10)1-2-8-3-5-11-6-4-8/h1-6H2,(H,9,10) | Definition date: | 2017-01-17 | Last modified: | 2017-10-27 | Release date: | 2017-11-01 | Identifier: | 3-(morpholin-4-yl)propanoic acid |
|
![8B1 8B1](https://data.pdbj.org/pdbjplus/data/cc/svg/8B1.svg) | 8B1 | Name: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide | Formula: | C31 H47 N5 O4 S | SMILES: | O=C(CCN1CCOCC1)NCC(NC(C(NC(CC)=O)Cc3sc2cc(C(C)C)ccc2n3)=O)C4CCCCC4 | InChi: | InChI=1S/C31H47N5O4S/c1-4-28(37)33-25(19-30-34-24-11-10-23(21(2)3)18-27(24)41-30)31(39)35-26(22-8-6-5-7-9-22)20-32-29(38)12-13-36-14-16-40-17-15-36/h10-11,18,21-22,25-26H,4-9,12-17,19-20H2,1-3H3,(H,32,38)(H,33,37)(H,35,39)/t25-,26+/m0/s1 | Definition date: | 2017-01-17 | Last modified: | 2017-10-27 | Release date: | 2017-11-01 | Identifier: | N-[(1S)-1-cyclohexyl-2-{[3-(morpholin-4-yl)propanoyl]amino}ethyl]-N~2~-propanoyl-3-[6-(propan-2-yl)-1,3-benzothiazol-2-yl]-L-alaninamide |
|
![A0T A0T](https://data.pdbj.org/pdbjplus/data/cc/svg/A0T.svg) | A0T | Name: | [4-[[4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-2-fluoranyl-5-methoxy-phenyl]-morpholin-4-yl-methanone | Formula: | C19 H21 F4 N5 O3 | SMILES: | CCNc1nc(Nc2cc(F)c(cc2OC)C(=O)N3CCOCC3)ncc1C(F)(F)F | InChi: | InChI=1S/C19H21F4N5O3/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27) | Definition date: | 2017-08-09 | Last modified: | 2017-10-20 | Release date: | 2017-10-25 | Identifier: | [4-[[4-(ethylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-2-fluoranyl-5-methoxy-phenyl]-morpholin-4-yl-methanone |
|
![A1K A1K](https://data.pdbj.org/pdbjplus/data/cc/svg/A1K.svg) | A1K | Name: | [4-[[5-chloranyl-4-(methylamino)-7~{H}-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxy-phenyl]-morpholin-4-yl-methanone | Formula: | C19 H21 Cl N6 O3 | SMILES: | CNc1nc(Nc2ccc(cc2OC)C(=O)N3CCOCC3)nc4[nH]cc(Cl)c14 | InChi: | InChI=1S/C19H21ClN6O3/c1-21-16-15-12(20)10-22-17(15)25-19(24-16)23-13-4-3-11(9-14(13)28-2)18(27)26-5-7-29-8-6-26/h3-4,9-10H,5-8H2,1-2H3,(H3,21,22,23,24,25) | Definition date: | 2017-08-09 | Last modified: | 2017-10-20 | Release date: | 2017-10-25 | Identifier: | [4-[[5-chloranyl-4-(methylamino)-7~{H}-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-methoxy-phenyl]-morpholin-4-yl-methanone |
|
![A1N A1N](https://data.pdbj.org/pdbjplus/data/cc/svg/A1N.svg) | A1N | Name: | (2~{R},6~{S})-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1~{H}-indazol-3-yl]pyrimidin-4-yl]morpholine | Formula: | C21 H25 N5 O2 | SMILES: | C[CH]1CN(C[CH](C)O1)c2cc(ncn2)c3n[nH]c4ccc(OC5(C)CC5)cc34 | InChi: | InChI=1S/C21H25N5O2/c1-13-10-26(11-14(2)27-13)19-9-18(22-12-23-19)20-16-8-15(28-21(3)6-7-21)4-5-17(16)24-25-20/h4-5,8-9,12-14H,6-7,10-11H2,1-3H3,(H,24,25)/t13-,14+ | Definition date: | 2017-08-09 | Last modified: | 2017-10-20 | Release date: | 2017-10-25 | Identifier: | (2~{R},6~{S})-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1~{H}-indazol-3-yl]pyrimidin-4-yl]morpholine |
|
![A3E A3E](https://data.pdbj.org/pdbjplus/data/cc/svg/A3E.svg) | A3E | Name: | 5-[4-(morpholin-4-ylmethyl)phenyl]-3-(1-propan-2-yl-1,2,3-triazol-4-yl)pyridin-2-amine | Formula: | C21 H26 N6 O | SMILES: | CC(C)n1cc(nn1)c2cc(cnc2N)c3ccc(CN4CCOCC4)cc3 | InChi: | InChI=1S/C21H26N6O/c1-15(2)27-14-20(24-25-27)19-11-18(12-23-21(19)22)17-5-3-16(4-6-17)13-26-7-9-28-10-8-26/h3-6,11-12,14-15H,7-10,13H2,1-2H3,(H2,22,23) | Definition date: | 2017-08-10 | Last modified: | 2017-10-20 | Release date: | 2017-10-25 | Identifier: | 5-[4-(morpholin-4-ylmethyl)phenyl]-3-(1-propan-2-yl-1,2,3-triazol-4-yl)pyridin-2-amine |
|
![79B 79B](https://data.pdbj.org/pdbjplus/data/cc/svg/79B.svg) | 79B | Name: | 11-[(2~{R})-2-[(2-pyridin-3-ylquinazolin-4-yl)amino]-2,3-dihydro-1~{H}-inden-5-yl]undec-10-ynoic acid | Formula: | C33 H34 N4 O2 | SMILES: | OC(=O)CCCCCCCCC#Cc1ccc2C[CH](Cc2c1)Nc3nc(nc4ccccc34)c5cccnc5 | InChi: | InChI=1S/C33H34N4O2/c38-31(39)16-8-6-4-2-1-3-5-7-12-24-17-18-25-21-28(22-27(25)20-24)35-33-29-14-9-10-15-30(29)36-32(37-33)26-13-11-19-34-23-26/h9-11,13-15,17-20,23,28H,1-6,8,16,21-22H2,(H,38,39)(H,35,36,37)/t28-/m1/s1 | Definition date: | 2016-09-15 | Last modified: | 2017-10-20 | Release date: | 2017-10-25 | Identifier: | 11-[(2~{R})-2-[(2-pyridin-3-ylquinazolin-4-yl)amino]-2,3-dihydro-1~{H}-inden-5-yl]undec-10-ynoic acid |
|
![7E4 7E4](https://data.pdbj.org/pdbjplus/data/cc/svg/7E4.svg) | 7E4 | Name: | 11-[(2~{S})-2-[(2-pyridin-3-ylquinazolin-4-yl)amino]-2,3-dihydro-1~{H}-inden-5-yl]undec-10-ynoic acid | Formula: | C33 H34 N4 O2 | SMILES: | OC(=O)CCCCCCCCC#Cc1ccc2C[CH](Cc2c1)Nc3nc(nc4ccccc34)c5cccnc5 | InChi: | InChI=1S/C33H34N4O2/c38-31(39)16-8-6-4-2-1-3-5-7-12-24-17-18-25-21-28(22-27(25)20-24)35-33-29-14-9-10-15-30(29)36-32(37-33)26-13-11-19-34-23-26/h9-11,13-15,17-20,23,28H,1-6,8,16,21-22H2,(H,38,39)(H,35,36,37)/t28-/m0/s1 | Definition date: | 2016-10-13 | Last modified: | 2017-10-20 | Release date: | 2017-10-25 | Identifier: | 11-[(2~{S})-2-[(2-pyridin-3-ylquinazolin-4-yl)amino]-2,3-dihydro-1~{H}-inden-5-yl]undec-10-ynoic acid |
|
![A1H A1H](https://data.pdbj.org/pdbjplus/data/cc/svg/A1H.svg) | A1H | Name: | 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)-1~{H}-pyrazol-3-one | Formula: | C13 H14 N8 O2 | SMILES: | O=C1N(NC=C1n2ccnn2)c3cc(ncn3)N4CCOCC4 | InChi: | InChI=1S/C13H14N8O2/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19/h1-2,7-9,17H,3-6H2 | Definition date: | 2017-08-09 | Last modified: | 2017-10-13 | Release date: | 2017-10-18 | Identifier: | 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)-1~{H}-pyrazol-3-one |
|
![7EJ 7EJ](https://data.pdbj.org/pdbjplus/data/cc/svg/7EJ.svg) | 7EJ | Name: | 1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]-5-phenyl-1H-pyrrole-2-carboxamide | Formula: | C30 H44 N4 O4 | SMILES: | C(CCn3c(C(N(CC(C)C)C2CNCC(C(=O)N1CCOCC1)C2)=O)ccc3c4ccccc4)COC | InChi: | InChI=1S/C30H44N4O4/c1-23(2)22-34(26-19-25(20-31-21-26)29(35)32-14-17-38-18-15-32)30(36)28-12-11-27(24-9-5-4-6-10-24)33(28)13-7-8-16-37-3/h4-6,9-12,23,25-26,31H,7-8,13-22H2,1-3H3/t25-,26+/m1/s1 | Definition date: | 2016-10-14 | Last modified: | 2017-10-13 | Release date: | 2017-10-18 | Identifier: | 1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]-5-phenyl-1H-pyrrole-2-carboxamide |
|
![7EK 7EK](https://data.pdbj.org/pdbjplus/data/cc/svg/7EK.svg) | 7EK | Name: | 5-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]-1-phenyl-1H-1,2,3-triazole-4-carboxamide | Formula: | C28 H42 N6 O4 | SMILES: | C(COC)CCc3c(C(N(CC(C)C)C2CNCC(C(N1CCOCC1)=O)C2)=O)nnn3c4ccccc4 | InChi: | InChI=1S/C28H42N6O4/c1-21(2)20-33(24-17-22(18-29-19-24)27(35)32-12-15-38-16-13-32)28(36)26-25(11-7-8-14-37-3)34(31-30-26)23-9-5-4-6-10-23/h4-6,9-10,21-22,24,29H,7-8,11-20H2,1-3H3/t22-,24+/m1/s1 | Definition date: | 2016-10-14 | Last modified: | 2017-10-13 | Release date: | 2017-10-18 | Identifier: | 5-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]-1-phenyl-1H-1,2,3-triazole-4-carboxamide |
|
![AQV AQV](https://data.pdbj.org/pdbjplus/data/cc/svg/AQV.svg) | AQV | Name: | 2-{2-oxo-2-[(4S)-2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl]ethyl}-1H-isoindole-1,3(2H)-dione | Formula: | C22 H22 N2 O3 | SMILES: | c12c(cccc1)C(N(C2=O)CC(N3c4c(C(CC3(C)C)C)cccc4)=O)=O | InChi: | InChI=1S/C22H22N2O3/c1-14-12-22(2,3)24(18-11-7-6-8-15(14)18)19(25)13-23-20(26)16-9-4-5-10-17(16)21(23)27/h4-11,14H,12-13H2,1-3H3/t14-/m0/s1 | Definition date: | 2017-07-24 | Last modified: | 2017-10-13 | Release date: | 2017-10-18 | Identifier: | 2-{2-oxo-2-[(4S)-2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl]ethyl}-1H-isoindole-1,3(2H)-dione |
|
![8W2 8W2](https://data.pdbj.org/pdbjplus/data/cc/svg/8W2.svg) | 8W2 | Name: | 2-[3-[[4,6-bis(chloranyl)-1~{H}-indol-2-yl]methylamino]propylamino]-3~{H}-quinazolin-4-one | Formula: | C20 H19 Cl2 N5 O | SMILES: | Clc1cc(Cl)c2cc(CNCCCNC3=Nc4ccccc4C(=O)N3)[nH]c2c1 | InChi: | InChI=1S/C20H19Cl2N5O/c21-12-8-16(22)15-10-13(25-18(15)9-12)11-23-6-3-7-24-20-26-17-5-2-1-4-14(17)19(28)27-20/h1-2,4-5,8-10,23,25H,3,6-7,11H2,(H2,24,26,27,28) | Definition date: | 2017-03-15 | Last modified: | 2017-10-06 | Release date: | 2017-10-11 | Identifier: | 2-[3-[[4,6-bis(chloranyl)-1~{H}-indol-2-yl]methylamino]propylamino]-3~{H}-quinazolin-4-one |
|
![U52 U52](https://data.pdbj.org/pdbjplus/data/cc/svg/U52.svg) | U52 | Name: | 2-[6-[[5-chloranyl-2-[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]pyrimidin-4-yl]amino]-1-methyl-2-oxidanylidene-quinolin-3-yl]oxy-~{N}-methyl-ethanamide | Formula: | C24 H29 Cl N6 O3 | SMILES: | CNC(=O)COC1=Cc2cc(Nc3nc(ncc3Cl)N4C[CH](C)C[CH](C)C4)ccc2N(C)C1=O | InChi: | InChI=1S/C24H29ClN6O3/c1-14-7-15(2)12-31(11-14)24-27-10-18(25)22(29-24)28-17-5-6-19-16(8-17)9-20(23(33)30(19)4)34-13-21(32)26-3/h5-6,8-10,14-15H,7,11-13H2,1-4H3,(H,26,32)(H,27,28,29)/t14-,15+ | Definition date: | 2017-01-18 | Last modified: | 2017-09-29 | Release date: | 2017-10-04 | Identifier: | 2-[6-[[5-chloranyl-2-[(3~{S},5~{R})-3,5-dimethylpiperidin-1-yl]pyrimidin-4-yl]amino]-1-methyl-2-oxidanylidene-quinolin-3-yl]oxy-~{N}-methyl-ethanamide |
|
![JAY JAY](https://data.pdbj.org/pdbjplus/data/cc/svg/JAY.svg) | JAY | Name: | (2R)-2-(2-fluorophenyl)-3-[2-[4-[(2R)-2-(2-fluorophenyl)-4-oxidanylidene-1,2-dihydroquinazolin-3-yl]piperidin-1-yl]ethyl]-1,2-dihydroquinazolin-4-one | Formula: | C35 H33 F2 N5 O2 | SMILES: | Fc1ccccc1[CH]2Nc3ccccc3C(=O)N2CCN4CCC(CC4)N5[CH](Nc6ccccc6C5=O)c7ccccc7F | InChi: | InChI=1S/C35H33F2N5O2/c36-28-13-5-1-9-24(28)32-38-30-15-7-3-11-26(30)34(43)41(32)22-21-40-19-17-23(18-20-40)42-33(25-10-2-6-14-29(25)37)39-31-16-8-4-12-27(31)35(42)44/h1-16,23,32-33,38-39H,17-22H2/t32-,33-/m1/s1 | Definition date: | 2017-02-27 | Last modified: | 2017-09-29 | Release date: | 2017-10-04 | Identifier: | (2~{R})-2-(2-fluorophenyl)-3-[2-[4-[(2~{R})-2-(2-fluorophenyl)-4-oxidanylidene-1,2-dihydroquinazolin-3-yl]piperidin-1-yl]ethyl]-1,2-dihydroquinazolin-4-one |
|